Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dipeptidyl-Peptidase IV Inhibitors × Breast × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Letrozole 39 Fulvestrant 37 Paclitaxel 34 Specimen Handling 32 pembrolizumab 30 Magnetic Resonance Spectroscopy 29 Trastuzumab 26 Anastrozole 22 ribociclib 21 Capecitabine 21 Biopsy 21 exemestane 19 Tamoxifen 18 Carboplatin 16 trastuzumab deruxtecan 15 pertuzumab 15 Cyclophosphamide 15 palbociclib 14 abemaciclib 14 Docetaxel 14 130-nm albumin-bound paclitaxel 14 Taxes 12 Radiotherapy 12 olaparib 10 inavolisib 10 Doxorubicin 10 Blood Specimen Collection 10 eribulin 9 X-Rays 9 tucatinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07436663 2026-02-27

SGLT2i/DPPi

Tanta University

Phase 4 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡